PHEN Clinical Trials Rally

Increasing the participation of African American men in prostate cancer clinical trials through education, awareness, support and collaborations. This portal provides clinical trials background information, details for specific trials, personal stories and other resources to support the Rally.

This information is not intended as medical advice for patients. Patients should consult their medical doctor for advice and recommendations about specific clinical trials.


"We must not be left behind with new prostate cancer treatments."

PHEN president and founder Thomas A. Farrington talks about his prostate cancer journey and the importance of African American men participating in clinical trials.

Information

Understanding the possible benefits for patients when participating in a clinical trial.

Clinical trials offer important and unique benefits to patients.

Information

Dr. J. Carter Presents Clinical Trials 101

Dr. Carter's brief video presentations provide basic information for patients to better understand clinical trials.

Information

What Are Clinical Trials?

Information that all patients need to know when considering enrolling into a clinical trial.

Information

ARASENS Clinical Trials Summary

For men who have metastatic cancer and who have never been treated with chemotherapy or immunotherapy.

Information

IPATential150 Clinical Trial

The IPATential150 clinical trial is to compare the effectiveness, safety, and response to the addition of the investigational new drug ipatasertib to the FDA approved agent abiraterone (Zytiga) plus prednisone/prednisolone in eligible patients with castration-resistant prostate cancer that has spread (metastatic).

Information

Triton 2 Clinical Trial

For patients with metastatic castration resistant prostate cancer that is progressing following treatment with Zytiga, Xtandi, and taxane based chemotherapy

Information

Triton 3 Clinical Trial

For patients where hormone therapy no longer keeps the PSA from increasing (metastatic castration resistant prostate cancer) with evidence of BRACA1, BRACA2, or ATM genetic mutations or alterations

Information

EMBARK Clinical Trial Summary

For patients with a rising PSA after being treated with surgery, radiation or both.

Information

ENACT Clinical Trial Summary

For patients considering active surveillance or currently undergoing active surveillance.

Information

The TRUMPET Registry

For men whose prostate cancer has grown or spread despite use of hormonal treatments to lower their PSA; Known as castration-resistant prostate cancer.

Information



A listing of all the prostate cancer clinical trials listed on clinicaltrials.gov that are currently recruiting patients.

Information

Prostate Cancer Clinical Trial Opportunities & Possible Benefits

J. J. Carter, MD, MPH, Assistant Professor, Harvard Medical School, PHEN Medical Advisor video presentations about Prostate Cancer Clinical Trial Opportunities & Possible Benefits

Information

Strategies For Increasing African American Participation in Clinical Trials at Duke

Dr. Steven Patierno, Deputy Director, Duke Cancer Institute at Duke Medical Center presents at PHEN's 2016 Summit.

Information

Overcoming Barriers to Clinical Trials Participation

Dr. Edith Mitchell, Director, Center to Eliminate Cancer Disparities, Sidney Kimmel Cancer Center at Thomas Jefferson University presents at PHEN's 2016 Summit.

Information

PHEN's Clinical Trials Rally Progress and Strategies

Dr. Gary L. Taylor, PHEN Medical Director of the Clinical Trials Rally presents at PHEN's 2017 Summit.

Information

Making Progress In African American Clinical Trial Enrollment

Dr. Gwendolyn Shang, Director of Medical Affairs at Pfizer, outlines progress being made in partnership with PHEN at 2017 Summit.

Information

Role of The Industry Advocacy Director in Clinical Trials

Ms. Gissoo Decotis, Deputy Director, Oncology Advocacy Relations at Bayer Healthcare, outlines the important role of internal industry advocacy at PHEN's 2017 Summit.

Information














PHEN,Inc. © 2018 All rights reserved